Thyrotoxicosis and dilated cardiomyopathy in developing countries. 2021

Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
College of Health Sciences, Mekelle University, Mekelle, Ethiopia.

BACKGROUND Thyrotoxicosis is the state of thyroid hormone excess. But, in sub-Saharan Africa (SSA), specifically Northern Ethiopia, scientific evidence about thyrotoxicosis and its cardiac complications like dilated cardiomyopathy is limited. Therefore, this study aimed to explore the thyrotoxicosis presentation and management and identify factors associated with dilated cardiomyopathy in a tertiary hospital in Northern Ethiopia. METHODS An institution-based cross-sectional study was conducted in Ayder Comprehensive Specialized Hospital from 2017 to 2018. Data from 200 thyrotoxicosis cases were collected using a structured questionnaire. After describing variables, logistic regression was conducted to identify independent predictors of dilated cardiomyopathy. Statistical significance was declared at p < 0.05. RESULTS Mean age at presentation of thyrotoxicosis was 45 years and females accounted for 89 % of the cases. The most frequent etiology was multinodular toxic goiter (51.5 %). As well, the most common symptoms and signs were palpitation and goiter respectively. Thyroid storm occurred in 6 % of the cases. Out of 89 patients subjected to echocardiography, 35 (39.3 %) of them had dilated cardiomyopathy. And, the odds of dilated cardiomyopathy were higher in patients who had atrial fibrillation (AOR = 15.95, 95 % CI:5.89-38.16, p = 0.001) and tachycardia (AOR = 2.73, 95 % CI:1.04-7.15, p = 0.040). All patients took propylthiouracil and 13.0 % of them experienced its side effects. Concerning β-blockers, propranolol was the most commonly (78.5 % of the cases) used drug followed by atenolol (15.0 %). Six patients underwent surgery. CONCLUSIONS In developing countries like Ethiopia, patients with thyrotoxicosis have no access to methimazole which is the first-line anti-thyroid drug. Besides, they greatly suffer from dilated cardiomyopathy (due to late presentation) and side effects of propylthiouracil. Therefore, we recommend that patients should get adequate health information about thyrotoxicosis and anti-thyroid drugs including their side effects. Additionally, hospitals and other concerned bodies should also avail of TSH tests and methimazole at an affordable cost. Furthermore, community awareness about iodized salt and iodine-rich foods should be enhanced.

UI MeSH Term Description Entries
D007455 Iodine A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically. Iodine-127,Iodine 127
D008297 Male Males
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D005002 Ethiopia An independent state in eastern Africa. Ethiopia is located in the Horn of Africa and is bordered on the north and northeast by Eritrea, on the east by Djibouti and Somalia, on the south by Kenya, and on the west and southwest by Sudan. Its capital is Addis Ababa. Federal Democratic Republic of Ethiopia
D005260 Female Females
D006044 Goiter, Nodular An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS. Nodular Goiter,Goiters, Nodular,Nodular Goiters

Related Publications

Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
December 1995, American heart journal,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
April 1999, Heart (British Cardiac Society),
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
August 2001, International journal of cardiology,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
September 1994, American heart journal,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
June 2001, The Journal of the Association of Physicians of India,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
July 1992, The American journal of cardiology,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
July 2006, The Journal of the Association of Physicians of India,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
November 1995, International journal of cardiology,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
May 1984, American journal of obstetrics and gynecology,
Bisrat Tesfay Abera, and Merhawit Atsbha Abera, and Gebretsadik Berhe, and Girmatsion Fisseha Abreha, and Hirut Teame Gebru, and Hiluf Ebuy Abraha, and Mohamedawel Mohamedniguss Ebrahim
January 2006, Irish medical journal,
Copied contents to your clipboard!